Skip to main content
Clinical Trials/NCT04192656
NCT04192656
Recruiting
Phase 4

The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

Beijing Tsinghua Chang Gung Hospital1 site in 1 country102 target enrollmentNovember 1, 2019

Overview

Phase
Phase 4
Intervention
Ginaton
Conditions
Sudden Hearing Loss
Sponsor
Beijing Tsinghua Chang Gung Hospital
Enrollment
102
Locations
1
Primary Endpoint
hearing threshold
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
December 2029
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ye Jingying

Director of the dept. of Otolaryngology, Head and Neck Surgery, and Director of the Center of Sleep Medicine

Beijing Tsinghua Chang Gung Hospital

Eligibility Criteria

Inclusion Criteria

  • aged \>= 18 and \<= 70,
  • diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI \> 15/h,
  • diagnosed with ISSHL by AAO-HNS 2019 criteria,
  • ISSHL onset within 1 week.

Exclusion Criteria

  • sudden hearing loss with certain causes,
  • with severe comorbid diseases,
  • pregnant or breast-feeding women,
  • AHI \<= 15/h,
  • hearing threshold recovered \> 50% when included,
  • previously regularly treated with PAP.

Arms & Interventions

medication

patients treated by medication only

Intervention: Ginaton

PAP plus medication

patients treated by both PAP and medication

Intervention: non-invasive positive airway pressure

PAP plus medication

patients treated by both PAP and medication

Intervention: Methylprednisolone Hemisuccinate

PAP plus medication

patients treated by both PAP and medication

Intervention: Ginaton

medication

patients treated by medication only

Intervention: Methylprednisolone Hemisuccinate

Outcomes

Primary Outcomes

hearing threshold

Time Frame: 3 months after onset of ISSHL

the recovery of hearing threshold which will be measured by pure tone audiometry

Study Sites (1)

Loading locations...

Similar Trials